Form 4 for INKT MiNK Therapeutics, Inc.
Accepted 2026-03-04 00:00:00 ET · period of report 2026-02-27 · accession 0001193125-26-091707 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-04 | 2026-02-27+ | INKT | Ryan Barbara | Dir | S - Sale | $10.85 | -500 | 22.0K | -2% | -$5,427 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 100 | $10.83 | 21,906 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-27 | S | D | 400 | $10.86 | 22,006 | D | — | — |